startups with seasoned industry veterans among their senior teams could have a better chance of securing the VC investment they need to fulfil their market potential



Source link https://www.forbes.com/sites/alisoncoleman/2018/07/24/the--biotech-----into-the-c-suite/

LEAVE A REPLY

Please enter your comment!
Please enter your name here